Jasper Therapeutics (JSPR) News Today $2.92 +0.05 (+1.56%) As of 01:24 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock JSPR Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPRAugust 1 at 10:00 AM | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPRJuly 31, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPRJuly 28, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPRJuly 27, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPRJuly 23, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPRJuly 22, 2025 | prnewswire.comJasper Therapeutics, Inc. (NASDAQ:JSPR) Receives Average Recommendation of "Moderate Buy" from AnalystsJuly 20, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPRJuly 18, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPRJuly 17, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPRJuly 14, 2025 | globenewswire.comHC Wainwright Issues Positive Estimate for JSPR EarningsJuly 14, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - JSPRJuly 12, 2025 | prnewswire.comJSPR Investors Have Opportunity to Join Jasper Therapeutics, Inc. Fraud Investigation with the Schall Law FirmJuly 11, 2025 | businesswire.comJasper Therapeutics Announces Corporate Reorganization and Other Cost ...July 11, 2025 | morningstar.comMJasper Therapeutics Announces 50% Workforce Reduction and ... - NasdaqJuly 11, 2025 | nasdaq.comUBS Reaffirms Their Buy Rating on Jasper Therapeutics (JSPR)July 9, 2025 | theglobeandmail.comJasper Therapeutics, Inc.: Jasper Therapeutics Announces Corporate Reorganization and Other Cost Cutting Measures to Extend Cash RunwayJuly 9, 2025 | finanznachrichten.deJasper Therapeutics Cutting Half of Staff After Study SetbackJuly 9, 2025 | marketwatch.comJasper Therapeutics Announces Corporate Reorganization and Other Cost Cutting Measures to Extend Cash RunwayJuly 9, 2025 | globenewswire.comJasper Therapeutics (NASDAQ:JSPR) Given Market Perform Rating at BMO Capital MarketsJuly 8, 2025 | marketbeat.comJasper Therapeutics Inc News (JSPR) - Investing.comJuly 8, 2025 | investing.comCantor Fitzgerald Downgrades Jasper Therapeutics (JSPR)July 8, 2025 | msn.comJasper Therapeutics (NASDAQ:JSPR) Lowered to "Neutral" Rating by Cantor FitzgeraldJuly 7, 2025 | marketbeat.comJasper Therapeutics Shares Fall On Briquilimab Drug Lot ProblemJuly 7, 2025 | benzinga.comJasper Therapeutics Reports Clinical Data Update from Briquilimab Studies in Chronic Spontaneous UrticariaJuly 7, 2025 | globenewswire.comJasper Therapeutics, Inc. (NASDAQ:JSPR) Receives Average Rating of "Buy" from BrokeragesJune 25, 2025 | marketbeat.comJasper Therapeutics stock maintains buy rating on positive urticaria dataJune 18, 2025 | investing.comJasper Therapeutics Reports Encouraging Results from SPOTLIGHT Phase 1b/2a Study of Briquilimab for Chronic Inducible UrticariaJune 15, 2025 | nasdaq.comJasper Therapeutics’ SWOT analysis: briquilimab’s potential in CSU stock scrutinizedJune 15, 2025 | investing.comJasper Therapeutics Reports Positive Data from 180mg Cohort in SPOTLIGHT Study of Briquilimab in Chronic Inducible UrticariaJune 14, 2025 | globenewswire.comAnalysts Offer Predictions for JSPR FY2026 EarningsJune 10, 2025 | marketbeat.comJasper Therapeutics Announces Briquilimab Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) Annual CongressJune 3, 2025 | globenewswire.comJasper Therapeutics, Inc. (NASDAQ:JSPR) Given Consensus Recommendation of "Buy" by BrokeragesJune 1, 2025 | marketbeat.comJasper Therapeutics (NASDAQ:JSPR) Will Have To Spend Its Cash WiselyMay 29, 2025 | finance.yahoo.comWoodline Partners LP Decreases Stake in Jasper Therapeutics, Inc. (NASDAQ:JSPR)May 26, 2025 | marketbeat.comJasper Therapeutics, Inc. (JSPR): Analysts See 914% Upside PotentialMay 21, 2025 | insidermonkey.comSoleus Capital Management L.P. Has $31.95 Million Stake in Jasper Therapeutics, Inc. (NASDAQ:JSPR)May 21, 2025 | marketbeat.comJasper Therapeutics to Present at RBC and Jefferies Global Healthcare Conferences on Briquilimab DevelopmentMay 16, 2025 | nasdaq.comJasper Therapeutics (NASDAQ:JSPR) Releases Earnings Results, Misses Expectations By $0.24 EPSMay 14, 2025 | marketbeat.comJasper Therapeutics to Present at Upcoming Investor ConferencesMay 14, 2025 | globenewswire.comJasper Therapeutics, Inc. (NASDAQ:JSPR) Shares Acquired by Integral Health Asset Management LLCMay 14, 2025 | marketbeat.comJasper Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 12, 2025 | globenewswire.comJasper Therapeutics (JSPR) Expected to Announce Earnings on TuesdayMay 8, 2025 | marketbeat.comJasper Therapeutics, Inc. (NASDAQ:JSPR) Shares Acquired by Braidwell LPMay 8, 2025 | marketbeat.comJasper Therapeutics, Inc. (NASDAQ:JSPR) Receives Consensus Recommendation of "Buy" from AnalystsMay 8, 2025 | marketbeat.comAlly Bridge Group NY LLC Decreases Stock Holdings in Jasper Therapeutics, Inc. (NASDAQ:JSPR)May 4, 2025 | marketbeat.comBoxer Capital Management LLC Buys New Shares in Jasper Therapeutics, Inc. (NASDAQ:JSPR)May 4, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Makes New $1.76 Million Investment in Jasper Therapeutics, Inc. (NASDAQ:JSPR)April 30, 2025 | marketbeat.comJasper Therapeutics, Inc. (NASDAQ:JSPR) Receives Average Rating of "Buy" from AnalystsApril 13, 2025 | marketbeat.comShort Interest in Jasper Therapeutics, Inc. (NASDAQ:JSPR) Decreases By 19.7%April 1, 2025 | marketbeat.com Get Jasper Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for JSPR and its competitors with MarketBeat's FREE daily newsletter. Email Address JSPR Media Mentions By Week JSPR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JSPR News Sentiment▼0.000.46▲Average Medical News Sentiment JSPR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JSPR Articles This Week▼23▲JSPR Articles Average Week Get Jasper Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for JSPR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies enGene News Cybin News Aclaris Therapeutics News China SXT Pharmaceuticals News Voyager Therapeutics News Journey Medical News SELLAS Life Sciences Group News Alector News Enanta Pharmaceuticals News Black Diamond Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:JSPR) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jasper Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jasper Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
